# Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

> **NCT02965703** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 81 (actual)

## Conditions studied

- Colorectal Adenoma
- Colorectal Carcinoma

## Interventions

- **DRUG:** Aspirin
- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Placebo Administration
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Rectal Biopsy

## Key facts

- **NCT ID:** NCT02965703
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-16
- **Primary completion:** 2023-01-31
- **Final completion:** 2026-12-24
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02965703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02965703, "Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02965703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*